Search

Burn registries are centralized datasets that collect patient data from specialized burn units. These registries have been used to establish epidemiological trends, assess burn care outcomes, benchmark quality of care indicators, plan and assess delivery of burn care, and conduct research efforts. While most studies using burn registries are observational in nature, there is growing evidence of registry-based randomized controlled trials (rRCTs) that offer advantages such as reduced data collection burden, cost reduction, low lost-to-follow-up rates, and increased generalizability. However, there is a need to measure the efficacy of burn registries in shaping healthcare systems and improving burn care outcomes. Studies on other disease registries have shown promising evidence of their impact on healthcare processes and costs, but there is currently limited research on burn registries in this regard. Evaluating the impact of burn registries on patient outcomes, clinical processes, and health system improvements should be a priority to protect funding for existing registries and support the implementation of burn registries in jurisdictions where they do not exist. [Extracted from the article]

Background: The widespread use of drugs in prisons leads to avoidable deaths, poorer health and a poor living environment. The contribution of psychoactive prescription drugs to this problem has received little attention in prison policy or at individual prescriber level. Aims: To determine the extent of unsafe and inappropriate prescribing of psychoactive medications in one UK prison using a newly developed medicines optimisation framework. Method: A medicines optimisation framework was developed based on principles of good prescribing. It was initiated on the opening of a new prison—HMP Berwyn—in February 2017. During the study period, all prisoners at HMP Berwyn were transferred from other prisons. The safety and appropriateness of psychoactive medications were evaluated de novo on reception at HMP Berwyn and during follow up, using the medicines optimisation framework. Results: About 1941 sentenced men arrived at HMP Berwyn between February 2017 and November 2018. Nearly one‐third (634, 33%) were on a prescribed psychoactive medication. Seventy‐five percent of these (474/634) required a prescription change due to appropriateness or safety concerns. Nearly half (295, 46.5%) received changes at reception despite having already undergone medicines reconciliation at their previous prison. Forty‐three percent (275/634) received changes at follow up, most commonly those who had no prior risks identified at reception. Conclusions: Inappropriate and unsafe prescribing of psychoactive medications is occurring in prisons despite mandatory medication reviews. Ongoing monitoring is required to reduce the risk from these medications. A medicines optimisation framework such as this could be adopted across other prisons, worldwide, to help contribute to risk reduction from drug use in prisons. Appropriately modified, a similar framework might help reduce inappropriate and harmful prescribing in hospitals and in the community. [ABSTRACT FROM AUTHOR]